ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0123

Improving Interpretation of Work Outcomes in Patients with Inflammatory Rheumatic Musculoskeletal Disease: General Population Reference Curves for Work Ability and At-work Productivity

Dafne Capelusnik1, Wouter Smeets2, Casper Webers3, Sofia Ramiro4, Elena Nikiphorou5, Roel Braekers2, Laura Boekel6, Gertjan Wolbink7 and Annelies Boonen8, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Data science institute, Hasselt University, Hasselt, Belgium, 3Maastricht University, Maastricht, Netherlands, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5King's College London, London, United Kingdom, 6Amsterdam Rheumatology and Immunology Center, Location Reade, Department of Rheumatology, Amsterdam, Netherlands, 7Reade, Amsterdam, Netherlands, 8Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, Netherlands

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, Outcome measures, population studies, Statistical methods, work

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0117–0144) Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Data on self-reported presenteeism (limitations or reduced work productivity at work) in persons with inflammatory rheumatic and musculoskeletal diseases (iRMD) are challenging to interpret without a population benchmark, as presenteeism likely also occurs in the general working population. Our objective was to establish percentile curves (reference intervals [RI]) for ability and productivity while at paid work in a general working population.

Methods: A cross-sectional study was nested within an ongoing prospective Dutch cohort study on COVID-19, including patients with iRMD and general population controls. Participants with paid work (≥12 working hours/week) reported on work ability (Work Ability Index, range 0-10 [worst-best ability]) and work productivity (Work Productivity and Activity Impairment scale item 5 on productivity loss, range 0-100% [no-complete productivity loss]). A generalized additive model for location, shape and scale parameters (GAMLSS) with a zero-one inflated beta distribution was chosen to assess the association of age, gender, educational level, full- or part time employment and job demands with each presenteeism instrument (work ability, work productivity). Next, GAMLSS was used to establish age-specific RIs percentile curves for controls, stratified by relevant determinants when needed. Finally, the proportion of controls compared to patients with optimal outcomes (work ability=10 and productivity loss=0%) was calculated.

Results: A total of 446 controls were included; 327 (73%) were female, mean age 53 (SD 11) years, 188 (42%) had university education, mean work ability was 8.7 (1.6) [median 9 (IQR 2-10)] and mean at-work productivity loss 11% (25%) [0 (0-100)]. Education influenced work ability as well as work productivity loss. Percentile curves revealed that work ability decreases and productivity loss at work increases with age (Fig 1). While more than 50% of controls reported at least some impairment in work ability, more than 75% indicated having no productivity loss at work. Non-university education was strongly associated with both presenteeism outcomes. Stratification of percentile curves for work ability by education showed high variability in work ability with worse as well as better scores in small proportions of the older (compared to younger) controls (Fig 2). For productivity loss, non-university educated controls experienced increase in productivity loss in the older age groups. Plotting data form 494 patients with iRMD into the percentile curves revealed patients were less likely to have optimal work ability [151/494 (31%) vs 169/390 (43%) in controls] or no productivity loss [305/494 (62%) in patients vs 328/390 (83%) in controls]. Across percentiles, differences between patients and controls were larger for work productivity than work ability independent of age.

Conclusion: In the general working population work ability and productivity while at work are not perfect, indicating we should be cautious to not overestimate impact of iRMD on presenteeism. Notwithstanding, iRMD had evident impact on presenteeism compared to population controls, and this effect is stronger on productivity (output) than on ability (difficulty).

Supporting image 1

Figure 1. Reference intervals and percentile curves for a) work ability and b) productivity loss at work.

Supporting image 2

Figure 2. Reference intervals and percentile curves for work ability and productivity loss at work in high educated (left) vs low/middle educated (right) population.


Disclosures: D. Capelusnik: None; W. Smeets: None; C. Webers: None; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, Galapagos, 5, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, UCB Pharma, 2, 5; E. Nikiphorou: AbbVie/Abbott, 6, Celltrion, 6, Eli Lilly, 6, fresenius, 6, Galapagos, 6, Gilead, 1, 6, Pfizer, 6, Sanofi, 6; R. Braekers: None; L. Boekel: None; G. Wolbink: None; A. Boonen: AbbVie, 2, 5, 6, Galapagos, 2, 6, Novartis, 2, 6, Pfizer, 5, 6, UCB Pharma, 2, 6.

To cite this abstract in AMA style:

Capelusnik D, Smeets W, Webers C, Ramiro S, Nikiphorou E, Braekers R, Boekel L, Wolbink G, Boonen A. Improving Interpretation of Work Outcomes in Patients with Inflammatory Rheumatic Musculoskeletal Disease: General Population Reference Curves for Work Ability and At-work Productivity [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/improving-interpretation-of-work-outcomes-in-patients-with-inflammatory-rheumatic-musculoskeletal-disease-general-population-reference-curves-for-work-ability-and-at-work-productivity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-interpretation-of-work-outcomes-in-patients-with-inflammatory-rheumatic-musculoskeletal-disease-general-population-reference-curves-for-work-ability-and-at-work-productivity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology